Literature DB >> 6199139

Identification of the hepatic asialo-glycoprotein receptor (hepatic lectin) as a component of liver specific membrane lipoprotein (LSP).

I G McFarlane, B M McFarlane, G N Major, P Tolley, R Williams.   

Abstract

Liver specific membrane lipoprotein (LSP), the target for anti-LSP antibodies in various liver diseases, is thought to be comprised of fragments of the hepatocellular plasma membrane. In the present study, therefore, evidence has been sought for the presence in LSP of the hepatocyte surface receptor (hepatic lectin) that binds desialylated glycoproteins. Eight guinea-pig anti-LSP antisera (four anti-human and four anti-rabbit LSP) were found to react by ELISA and/or RIA against affinity purified human and rabbit hepatic lectin. Binding of the antisera to 125I-hepatic lectins was inhibited by the unlabelled lectins, by human and rabbit LSP and by purified rabbit liver plasma membranes but not by a 50,000-fold excess of kidney homogenate. The results indicate that hepatic lectin is a liver specific, species cross-reactive antigen comprising about 0.25% of the protein in LSP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199139      PMCID: PMC1535812     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Chemical and physical properties of an hepatic membrane protein that specifically binds asialoglycoproteins.

Authors:  T Kawasaki; G Ashwell
Journal:  J Biol Chem       Date:  1976-03-10       Impact factor: 5.157

2.  A rapid method for the isolation of rat liver plasma membranes using an aqueous two-phase polymer system.

Authors:  L Lesko; M Donlon; G V Marinetti; J D Hare
Journal:  Biochim Biophys Acta       Date:  1973-06-22

3.  Subcellular distribution of a mammalian hepatic binding protein specific for asialoglycoproteins.

Authors:  W E Pricer; G Ashwell
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

Review 4.  Hepatic clearance of serum glycoproteins.

Authors:  I G McFarlane
Journal:  Clin Sci (Lond)       Date:  1983-02       Impact factor: 6.124

5.  Quantitation of submicrogram quantities of protein by an improved protein-dye binding assay.

Authors:  J C Bearden
Journal:  Biochim Biophys Acta       Date:  1978-04-26

6.  Liver-specific antigens of different species. II. Localization of a membrane antigen at cell surface of isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; J Freudenberg
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

7.  Purification and characterization of human liver-specific membrane lipoprotein (LSP).

Authors:  I G McFarlane; B M Wojcicka; G M Zucker; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

8.  Occurrence and significance of antibody to liver-specific membrane lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases.

Authors:  S Kakumu; Y Arakawa; H Goji; T Kashio; K Yata
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

9.  Demonstration of binding sites for IgG Fc and the third complement component (C3) on isolated hepatocytes.

Authors:  U Hopf; K H Meyer zum Büschenfelde; M P Dierich
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

10.  Leukocyte migration inhibition in response to biliary antigens in primary biliary cirrhosis, sclerosing cholangitis, and other chronic liver diseases.

Authors:  I G McFarlane; B M Wojcicka; D C Tsantoulas; B C Portmann; A L Eddleston; R Williams
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

View more
  27 in total

Review 1.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Autoantibodies as prognostic markers in autoimmune liver disease.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

Review 3.  Immunological aspects of liver disease.

Authors:  A L Eddleston; P T Donaldson; J E Hegarty; B D Reed
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 4.  Chronic active hepatitis.

Authors:  P J Johnson; I G McFarlane
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 5.  Cellular mechanisms of hepatocyte damage and regulatory mechanisms in autoimmune chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Isolation and characterization of proteolipids from rat liver (LSP) and kidney (KSP).

Authors:  D Jüngst; J Blumenstingl; W H Caselmann
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

Review 7.  Immunological aspects of chronic active hepatitis.

Authors:  S Vento; A L Eddleston
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

8.  The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.

Authors:  U Sundin; Z Heigl; K G Sundqvist
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

9.  Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.

Authors:  A M Yamamoto; C Mura; C De Lemos-Chiarandini; R Krishnamoorthy; F Alvarez
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

10.  Human asialoglycoprotein receptor as an autoantigen in chronic hepatitis.

Authors:  K H Meyer zum Büschenfelde; U Treichel; H Löhr; B Fleischer; T Poralla
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.